Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2024-2031

Report ID: 922017 | Published Date: Jan 2025 | No. of Page: 95 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 5α-Reductase Inhibitors
        1.2.3 Gonadotropin-releasing Hormone Agonists
    1.3 Market by Application
        1.3.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Orthopedic Clinics
        1.3.4 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Perspective (2016-2027)
    2.2 Spinal and Bulbar Muscular Atrophy Treatment Growth Trends by Regions
        2.2.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Spinal and Bulbar Muscular Atrophy Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Spinal and Bulbar Muscular Atrophy Treatment Industry Dynamic
        2.3.1 Spinal and Bulbar Muscular Atrophy Treatment Market Trends
        2.3.2 Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
        2.3.3 Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
        2.3.4 Spinal and Bulbar Muscular Atrophy Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue
        3.1.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue (2016-2021)
        3.1.2 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Spinal and Bulbar Muscular Atrophy Treatment Revenue
    3.4 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio
        3.4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2020
    3.5 Spinal and Bulbar Muscular Atrophy Treatment Key Players Head office and Area Served
    3.6 Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
    3.7 Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Type
    4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027)

5 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Application
    5.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
    6.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
        6.2.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
        6.2.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
        6.2.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
    6.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
        6.3.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
        6.3.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
        6.3.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
    6.4 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
        6.4.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
        6.4.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
    7.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
        7.2.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
    7.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
        7.3.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
    7.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
        7.4.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
        8.2.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
        8.3.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region
        8.4.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
    9.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
        9.2.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
    9.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
        9.3.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
    9.4 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
        9.4.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
        10.2.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
        10.3.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
        10.4.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.1.4 AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.1.5 AbbVie Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Details
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.2.4 Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.2.5 Pfizer Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.3.4 GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.4.4 Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Century Pharmaceuticals
        11.5.1 Century Pharmaceuticals Company Details
        11.5.2 Century Pharmaceuticals Business Overview
        11.5.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.5.4 Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.5.5 Century Pharmaceuticals Recent Development
    11.6 Astellas Pharma
        11.6.1 Astellas Pharma Company Details
        11.6.2 Astellas Pharma Business Overview
        11.6.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.6.4 Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.6.5 Astellas Pharma Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Details
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.7.4 Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.7.5 Sanofi Recent Development
    11.8 Boehringer Ingelheim International
        11.8.1 Boehringer Ingelheim International Company Details
        11.8.2 Boehringer Ingelheim International Business Overview
        11.8.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Introduction
        11.8.4 Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
        11.8.5 Boehringer Ingelheim International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of 5α-Reductase Inhibitors
    Table 3. Key Players of Gonadotropin-releasing Hormone Agonists
    Table 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2016-2021)
    Table 8. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2022-2027)
    Table 10. Spinal and Bulbar Muscular Atrophy Treatment Market Trends
    Table 11. Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
    Table 12. Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
    Table 13. Spinal and Bulbar Muscular Atrophy Treatment Market Restraints
    Table 14. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2020)
    Table 17. Ranking of Global Top Spinal and Bulbar Muscular Atrophy Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
    Table 21. Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 64. AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 65. AbbVie Recent Development
    Table 66. Pfizer Company Details
    Table 67. Pfizer Business Overview
    Table 68. Pfizer Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 69. Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 70. Pfizer Recent Development
    Table 71. GlaxoSmithKline Company Details
    Table 72. GlaxoSmithKline Business Overview
    Table 73. GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 74. GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 75. GlaxoSmithKline Recent Development
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 79. Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 80. Johnson & Johnson Recent Development
    Table 81. Century Pharmaceuticals Company Details
    Table 82. Century Pharmaceuticals Business Overview
    Table 83. Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 84. Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 85. Century Pharmaceuticals Recent Development
    Table 86. Astellas Pharma Company Details
    Table 87. Astellas Pharma Business Overview
    Table 88. Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 89. Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 90. Astellas Pharma Recent Development
    Table 91. Sanofi Company Details
    Table 92. Sanofi Business Overview
    Table 93. Sanofi Spinal and Bulbar Muscular Atrophy Treatment Product
    Table 94. Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 95. Sanofi Recent Development
    Table 96. Boehringer Ingelheim International Company Details
    Table 97. Boehringer Ingelheim International Business Overview
    Table 98. Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021) & (US$ Million)
    Table 99. Boehringer Ingelheim International Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type: 2020 VS 2027
    Figure 2. 5α-Reductase Inhibitors Features
    Figure 3. Gonadotropin-releasing Hormone Agonists Features
    Figure 4. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Orthopedic Clinics Case Studies
    Figure 7. Ambulatory Surgical Centers Case Studies
    Figure 8. Spinal and Bulbar Muscular Atrophy Treatment Report Years Considered
    Figure 9. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Spinal and Bulbar Muscular Atrophy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Players in 2020
    Figure 14. Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Spinal and Bulbar Muscular Atrophy Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2020
    Figure 16. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 20. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 21. North America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 22. United States Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Share by Region (2016-2027)
    Figure 38. China Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Spinal and Bulbar Muscular Atrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. AbbVie Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 58. Pfizer Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 61. Century Pharmaceuticals Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 62. Astellas Pharma Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 63. Sanofi Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 64. Boehringer Ingelheim International Revenue Growth Rate in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Pfizer
GlaxoSmithKline
Johnson & Johnson
Century Pharmaceuticals
Astellas Pharma
Sanofi
Boehringer Ingelheim International
Frequently Asked Questions
Spinal and Bulbar Muscular Atrophy Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Spinal and Bulbar Muscular Atrophy Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Spinal and Bulbar Muscular Atrophy Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

kyphoplasty Systems

Growing prevalence of osteopenia and osteoporosis due to the increasing elderly population and gr ... Read More